September 29, 2025

Pharma shifts and tech resilience shape a new mood in European equities

European stocks are catching lift from pharma reshuffles and tech rebounds even as Lufthansa’s bold cost cuts raise the stakes for execution...

Copper market edges towards a strategic inflection

Tighter supply and resilient demand are reinforcing copper’s role as a strategic pillar of global growth and investor opportunity...

FTSE share prices climb as healthcare momentum meets US data focus

Momentum in UK healthcare stocks is reshaping the FTSE’s profile just as US jobs data becomes the next major inflection point...

Helium and its pivotal role in critical industries

Helium’s scarcity and irreplaceability in cryogenics make it one of the few industrial gases where supply risk can become a strategic concern...

Asia steadies as investors navigate policy shifts and US uncertainty

Asia steadies as technology strength offsets global uncertainty while investors await key central bank signals...

Palm oil finds fresh momentum amid energy and trade shifts

Palm oil futures are staging a modest rebound, hinting at deeper structural shifts linking energy price moves, seasonal demand, and export policy shifts...

Thor Energy highlights strategic pivot to hydrogen and helium in 2025 Annual Results

Thor Energy has reported audited results for the year ended 30 June 2025, marking a major strategic shift to natural hydrogen and helium exploration in South Australia...

Gold’s new threshold suggests a shift in risk appetite

Gold’s push past $3,800/oz signals shifting assumptions about central banks and risk...

Signs of a subtle shift in China’s market mood

China’s rally now speaks less of stimulus and more of a change in the rules, from low-price warfare to disciplined profitability...

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook with a 24.59% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent player in the biotechnology sector, particularly in the niche field of genetic therapies for rare diseases. As of the latest financial update,..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 23% Upside Potential in the Innovative Organ Transplant Sector

TransMedics Group, Inc. (NASDAQ: TMDX) presents a compelling opportunity for investors seeking exposure to the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.88 billion,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: 26% Revenue Growth and Promising Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out as a formidable player in the healthcare sector, specifically within the medical devices industry. The company’s focus on developing and commercializing cutting-edge ambulatory..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Promising Biotech Play with 58.58% Potential Upside

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering entity in the biotechnology industry, is garnering attention from investors with its innovative approach to RNA therapeutics. Specializing in antibody oligonucleotide conjugates (AOCs),..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Uncovering a 22% Upside Potential Amidst Robust Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS), a leading player in the biotechnology sector, has caught the attention of investors with its promising genetic medicines portfolio and impressive growth metrics. As a..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring an 18.64% Potential Upside in the Rare Disease Biotech Space

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.59 billion, this Boston-based company focuses..

Charles River Laboratories (CRL) Stock Analysis: Navigating Market Volatility with a 19.64% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the forefront of the Healthcare sector, specializing in the Diagnostics & Research industry. With a market capitalization of $7.31 billion, Charles..

Cytokinetics, Incorporated (CYTK): Biotech Stock with 48% Upside Potential and Robust Revenue Growth

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a market capitalization of $6.03 billion and a formidable presence in muscle biology drug development. This late-stage biopharmaceutical..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, stands at a pivotal moment in its journey, offering an intriguing opportunity for investors in the healthcare sector. With a market..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Revenue Growth and Promising Pipeline Signal Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling figure in the biotechnology sector, captivating investors with its impressive revenue growth and innovative pipeline. Headquartered in Morrisville, North Carolina, TG..

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 86.16% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is quietly navigating the healthcare sector with a focused mission to develop, manufacture, and market plasma-derived biologics targeting..

Search

Funds

September 29, 2025

Pharma shifts and tech resilience shape a new mood in European equities

European stocks are catching lift from pharma reshuffles and tech rebounds even as Lufthansa’s bold cost cuts raise the stakes for execution...

Copper market edges towards a strategic inflection

Tighter supply and resilient demand are reinforcing copper’s role as a strategic pillar of global growth and investor opportunity...

FTSE share prices climb as healthcare momentum meets US data focus

Momentum in UK healthcare stocks is reshaping the FTSE’s profile just as US jobs data becomes the next major inflection point...

Helium and its pivotal role in critical industries

Helium’s scarcity and irreplaceability in cryogenics make it one of the few industrial gases where supply risk can become a strategic concern...

Asia steadies as investors navigate policy shifts and US uncertainty

Asia steadies as technology strength offsets global uncertainty while investors await key central bank signals...

Palm oil finds fresh momentum amid energy and trade shifts

Palm oil futures are staging a modest rebound, hinting at deeper structural shifts linking energy price moves, seasonal demand, and export policy shifts...

Thor Energy highlights strategic pivot to hydrogen and helium in 2025 Annual Results

Thor Energy has reported audited results for the year ended 30 June 2025, marking a major strategic shift to natural hydrogen and helium exploration in South Australia...

Gold’s new threshold suggests a shift in risk appetite

Gold’s push past $3,800/oz signals shifting assumptions about central banks and risk...

Signs of a subtle shift in China’s market mood

China’s rally now speaks less of stimulus and more of a change in the rules, from low-price warfare to disciplined profitability...
Search

Funds

September 29, 2025

FTSE 100

Funds